Uric Acid as a Biomarker and a Therapeutic Target in Diabetes
- 1 June 2015
- journal article
- review article
- Published by Elsevier BV in Canadian Journal of Diabetes
- Vol. 39 (3), 239-246
- https://doi.org/10.1016/j.jcjd.2014.10.013
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluationRedox Biology, 2013
- Renal Transport of Uric Acid: Evolving Concepts and UncertaintiesAdvances in Chronic Kidney Disease, 2012
- Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid AccumulationPLOS ONE, 2012
- Uric Acid as a Mediator of Diabetic NephropathySeminars in Nephrology, 2011
- Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan TrialHypertension, 2011
- Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta‐AnalysisCardiovascular Therapeutics, 2011
- Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney DiseaseAmerican Journal of Nephrology, 2011
- Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes studyNephrology Dialysis Transplantation, 2010
- Early nephropathy in type 1 diabetes: the importance of early renal function declineCurrent Opinion in Nephrology and Hypertension, 2009
- Lowering serum urate does not improve endothelial function in patients with type 2 diabetesDiabetologia, 2007